Seung Ok Lee Selected Research

balsalazide (Colazal)

1/2017	Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation.
7/2015	Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seung Ok Lee Research Topics

Disease

11	Neoplasms (Cancer) 05/2021 - 10/2009
7	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 10/2012
6	Chronic Hepatitis B 01/2019 - 09/2007
3	Infections 01/2019 - 01/2014
3	Hemorrhage 01/2019 - 09/2011
2	Body Weight (Weight, Body) 05/2021 - 01/2017
2	Abscess 02/2021 - 03/2006
2	Disease Progression 01/2021 - 05/2015
2	Acute Cholecystitis 07/2020 - 01/2018
2	Hyperplasia 06/2020 - 09/2019
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 07/2016
2	Carcinogenesis 01/2017 - 05/2015
2	Inflammation (Inflammations) 01/2017 - 10/2012
2	Colitis-Associated Neoplasms 01/2017 - 05/2015
2	Ulcerative Colitis 01/2017 - 06/2006
2	Sepsis (Septicemia) 10/2016 - 03/2006
2	Fibrosis (Cirrhosis) 07/2012 - 06/2012
2	Chronic Hepatitis C 07/2012 - 01/2010
1	Diarrhea 05/2021
1	Weight Loss (Weight Reduction) 05/2021
1	Mucositis 05/2021
1	Liver Abscess 02/2021
1	Diabetes Mellitus 02/2021
1	Hypoalbuminemia 02/2021
1	Pyogenic Liver Abscess 02/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Vomiting 07/2020
1	Lymphatic Metastasis 01/2019
1	Pancreatic Pseudocyst 01/2019
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Neoplasm Metastasis (Metastasis) 05/2016
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2015
1	Hepatocellular Carcinoma (Hepatoma) 05/2015
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2015
1	Bacterial Infections (Bacterial Infection) 05/2015
1	Bile Duct Neoplasms (Bile Duct Cancer) 09/2014
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2014
1	Stomach Neoplasms (Stomach Cancer) 07/2013
1	Virus Diseases (Viral Diseases) 10/2012
1	Muscular Diseases (Myopathy) 10/2012
1	Migraine Disorders (Migraine) 10/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2012

Drug/Important Bio-Agent (IBA)

7	parthenolideIBA 01/2017 - 07/2012
4	MetalsIBA 01/2019 - 12/2009
3	Antiviral Agents (Antivirals)IBA 05/2015 - 05/2010
3	Lamivudine (Epivir)FDA Link 01/2014 - 09/2007
2	CytokinesIBA 05/2021 - 10/2016
2	C-Reactive ProteinIBA 02/2021 - 05/2015
2	ProcalcitoninIBA 02/2021 - 10/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2016
2	MicroRNAs (MicroRNA)IBA 10/2018 - 05/2016
2	balsalazide (Colazal)FDA LinkGeneric 01/2017 - 07/2015
2	adefovirIBA 01/2014 - 09/2007
2	clevudineIBA 10/2012 - 05/2010
2	Thioacetamide (Thioacetamid)IBA 07/2012 - 06/2012
2	Ribavirin (Virazole)FDA LinkGeneric 07/2012 - 01/2010
1	Superoxide DismutaseIBA 05/2021
1	Autophagy-Related ProteinsIBA 05/2021
1	imisopasem manganeseIBA 05/2021
1	Fluorouracil (Carac)FDA LinkGeneric 05/2021
1	SilverIBA 06/2020
1	Messenger RNA (mRNA)IBA 01/2019
1	Tenofovir (Viread)FDA Link 01/2019
1	Anoctamin-1IBA 01/2019
1	Dinoprostone (PGE2)FDA Link 10/2018
1	ElectrolytesIBA 01/2018
1	ProdrugsIBA 01/2017
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2017
1	Interleukin-5 (Interleukin 5)IBA 10/2016
1	Interleukin-10 (Interleukin 10)IBA 10/2016
1	Interleukin-6 (Interleukin 6)IBA 10/2016
1	Glutamine (L-Glutamine)FDA Link 07/2016
1	Carbon Tetrachloride (Tetrachloromethane)IBA 07/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Pharmaceutical PreparationsIBA 07/2015
1	Antineoplastic Agents (Antineoplastics)IBA 05/2015
1	Proteins (Proteins, Gene)FDA Link 05/2015
1	Hemoglobins (Hemoglobin)IBA 05/2015
1	AlbuminsIBA 05/2015
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 03/2015
1	LigandsIBA 03/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2014
1	BilirubinIBA 01/2014
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2014
1	entecavir FDA Link 01/2014
1	lipoarabinomannan (LAM)IBA 01/2014
1	Hemostatics (Antihemorrhagics)IBA 07/2013
1	Annexin A5IBA 10/2012
1	Bisbenzimidazole (Hoechst 33258)IBA 10/2012

Therapy/Procedure

9	Therapeutics 01/2019 - 01/2010
7	Stents 07/2020 - 12/2009
3	Self Expandable Metallic Stents 06/2020 - 05/2012
2	Cholecystectomy 07/2020 - 01/2018
2	Intraperitoneal Injections 07/2016 - 10/2012
1	Length of Stay 02/2021
1	Catheters 02/2021
1	Laparoscopic Cholecystectomy 01/2018
1	Endoscopic Hemostasis 07/2013